ArticleAntimicrobial agents and chemotherapy2019
Genomic and Functional Analysis of Emerging Virulent and Multidrug-Resistant
Open access · bronzeAbstract read
In one paragraph
Article in Antimicrobial agents and chemotherapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.
0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
10.1field-weighted citation impact, top 1% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
68 citing papers in PubMed, 97 citations in OpenAlex.
- Intestinal colonization of weaner pigs by extended-spectrum-β-lactamase-encoding Escherichia coli classified for differential host-association using a phylogenetics-based approach.Scientific reports · 2026Article
- Tracking Extended-Spectrum β-Lactamase-ProducingAntibiotics (Basel, Switzerland) · 2026Article
- [Development and spread of antibiotic resistance in the environment due to increased anthropogenic input of antibiotic residues and resistant pathogens].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2026Review
- Molecular profiling ofOpen veterinary journal · 2026Article
- Comparative genomic analyses ofmSystems · 2026Article
- Phenotypic and genomic profiling of multidrug-resistant Escherichia coli and Klebsiella pneumoniae isolated from Intensive Care Unit patients in Kenya.BMC microbiology · 2026Article
- Genomic epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Mwanza, Tanzania.Journal of global antimicrobial resistance · 2026Article
- Genomic and functional characterization of the L‑sorbose phosphotransferase system in high-riskmSystems · 2026Article
- An integrated phenotypic and genomic approach to characterize MBL-producing Enterobacterales strains circulating in a Sicilian transplant center.Microbiology spectrum · 2026Article
- Genomic profiling of ESBL/AmpC-producingFrontiers in microbiology · 2026Article
- Genomic Insights intoMicroorganisms · 2025Article
- ChronicInternational journal of molecular sciences · 2025Article
- ImprovedMicrobial genomics · 2025Article
- First national study on genomic profiling ofEnvironmental challenges (Amsterdam, Netherlands) · 2025Article
- Genotypic characterization of extended-spectrum beta-lactamase-producingMicrobiology spectrum · 2025Article
- Genomic insight into the high-risk hypervirulent multidrug resistant enteroaggregative-hemorrhagicGene reports · 2025Article
- Article
- Ecological and public health dimensions of ESBL-producingVeterinary world · 2025Review
- Prevalence and molecular characterization of ESBL-producing Escherichia coli isolated from broiler chicken and their respective farms environment in Malaysia.BMC microbiology · 2024Article
- Molecular Surveillance of Multidrug-Resistant Bacteria among Refugees from Afghanistan in 2 US Military Hospitals during Operation Allies Refuge, 2021.Emerging infectious diseases · 2024Article
8 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors at 14 institutions in 10 countries.
Katharina Schaufler *Pharmaceutical Microbiology, Institute of Pharmacy, University of Greifswald, Greifswald, Germany.
Torsten Semmler *NG 1-Microbial Genomics, Robert Koch Institute, Berlin, Germany.ORCID 0000-0002-2225-7267
Lothar H WielerRobert Koch Institute, Berlin, Germany.
Darren J TrottAustralian Centre for Antimicrobial Resistance Ecology, School of Animal and Veterinary Sciences, The University of Adelaide, Roseworthy, Australia.
Johann PitoutCalgary Laboratory Services, Diagnostic and Scientific Centre, Calgary, Alberta, Canada.
Gisele PeiranoCalgary Laboratory Services, Diagnostic and Scientific Centre, Calgary, Alberta, Canada.
Jonas BonnedahlKalmar County Council, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Monika DolejskaDepartment of Biology and Wildlife Diseases, Faculty of Veterinary Hygiene and Ecology, University of Veterinary and Pharmaceutical Sciences Brno, Brno-Královo Pole, Czech Republic.
Ivan LiterakDepartment of Biology and Wildlife Diseases, Faculty of Veterinary Hygiene and Ecology, University of Veterinary and Pharmaceutical Sciences Brno, Brno-Královo Pole, Czech Republic.
Stephan FuchsDivision 13: Nosocomial Pathogens and Antibiotic Resistances, Department of Infectious Diseases, Robert Koch Institute, Wernigerode, Germany.
Niyaz AhmedInternational Center for Diarrheal Disease Research-Bangladesh, Dhaka, Bangladesh.
Mirjam GrobbelUnit Epidemiology, Zoonoses and Antimicrobial Resistance, Department Biological Safety, German Federal Institute for Risk Assessment, Berlin, Germany.
Carmen TorresUniversidad de La Rioja, Area de Bioquímica y Biología Molecular, Logroño, Spain.
Alan McNallyInstitute of Microbiology and Infection, University of Birmingham, Birmingham, United Kingdom.
Derek PickardThe Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
Christa EwersInstitute of Hygiene and Infectious Diseases of Animals, Justus Liebig University Giessen, Giessen, Germany.ORCID 0000-0001-6167-1340
Nicholas J CroucherFaculty of Medicine, School of Public Health, Imperial College, London, United Kingdom.
Jukka Corander *The Wellcome Trust Sanger Institute, Cambridge, United Kingdom.
Sebastian Guenther *Institute of Microbiology and Epizootics, Free University Berlin, Berlin, Germany sebastian.guenther@uni-greifswald.de.
Robert Koch Institute · DEUniversität Greifswald · DEUniversity of Calgary · CAUniversity of Veterinary Sciences Brno · CZFederal Institute for Risk Assessment · DEImperial College London · GBInternational Centre for Diarrhoeal Disease Research · BDJustus-Liebig-Universität Gießen · DELinköping University · SEThe University of Adelaide · AUUniversidad de La Rioja · ESUniversity of Birmingham · GBUniversity of Helsinki · FIWellcome Sanger Institute · GB
Funding
Wellcome Trust
Abstract
The pathogenic extended-spectrum-beta-lactamase (ESBL)-producing
Indexed as
AnimalsAnti-Bacterial AgentsBacteremiabeta-LactamasesBiofilmsChickensDrug Resistance, Multiple, BacterialEscherichia coliEscherichia coli InfectionsGenomicsHumansMultilocus Sequence TypingPlasmidsUrinary Tract InfectionsVirulenceVirulence FactorsAnti-Bacterial Agentsbeta-LactamasesVirulence Factorsbiofilm formationESBL-producing clonal lineagesMDRNFDS modelingphylogeneticsST648virulence
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.